DK46988D0 - Fremgangsmaade til fremstilling af katteleukaemivirusantigener og anvendelsen heraf - Google Patents

Fremgangsmaade til fremstilling af katteleukaemivirusantigener og anvendelsen heraf

Info

Publication number
DK46988D0
DK46988D0 DK046988A DK46988A DK46988D0 DK 46988 D0 DK46988 D0 DK 46988D0 DK 046988 A DK046988 A DK 046988A DK 46988 A DK46988 A DK 46988A DK 46988 D0 DK46988 D0 DK 46988D0
Authority
DK
Denmark
Prior art keywords
virus
ukaemi
antigenes
procedure
cattle
Prior art date
Application number
DK046988A
Other languages
Danish (da)
English (en)
Other versions
DK46988A (da
Inventor
Gerald A Beltz
Dante J Marciani
Chung-Ho Hung
Charlotte A Kensil
Original Assignee
Cambridge Bioscience Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cambridge Bioscience Corp filed Critical Cambridge Bioscience Corp
Publication of DK46988D0 publication Critical patent/DK46988D0/da
Publication of DK46988A publication Critical patent/DK46988A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK046988A 1986-05-30 1988-01-29 Fremgangsmaade til fremstilling af katteleukaemivirusantigener og anvendelsen heraf DK46988A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86858586A 1986-05-30 1986-05-30
PCT/US1987/001278 WO1987007301A1 (en) 1986-05-30 1987-05-29 Method of preparation and use for feline leukemia virus antigens

Publications (2)

Publication Number Publication Date
DK46988D0 true DK46988D0 (da) 1988-01-29
DK46988A DK46988A (da) 1988-01-29

Family

ID=25351957

Family Applications (1)

Application Number Title Priority Date Filing Date
DK046988A DK46988A (da) 1986-05-30 1988-01-29 Fremgangsmaade til fremstilling af katteleukaemivirusantigener og anvendelsen heraf

Country Status (12)

Country Link
EP (1) EP0247904B1 (de)
JP (1) JP2656521B2 (de)
AT (1) ATE93394T1 (de)
AU (1) AU607427B2 (de)
DE (1) DE3787121T2 (de)
DK (1) DK46988A (de)
ES (1) ES2058113T3 (de)
IL (1) IL82720A0 (de)
NZ (1) NZ220500A (de)
PT (1) PT84976B (de)
WO (1) WO1987007301A1 (de)
ZA (1) ZA873922B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5152982A (en) * 1984-03-26 1992-10-06 Chiron Corporation Compositions and methods for FeLV vaccination
EP0377842B1 (de) * 1988-12-13 1995-10-04 President And Fellows Of Harvard College Prototypische FeLV-Isolate für die Verwendung als Krankheitsmuster oder Impfstoffe
ES2177530T3 (es) * 1991-11-08 2002-12-16 Upjohn Co Vacunas contra el virus de la leucemia felina.
GB9210337D0 (en) * 1992-05-14 1992-07-01 Univ Court Of The University O Feline leukaemia virus vaccine
US6013506A (en) * 1995-06-05 2000-01-11 Wardley; Richard C. Feline leukemia virus vaccines
US6248582B1 (en) * 1997-10-08 2001-06-19 Imran Khan Gene deleted recombinant FeLV proviral DNA for production of vaccines against FeLV
EP1757304A1 (de) 2005-08-26 2007-02-28 Bundesrepublik Deutschland vertreten durch das Bundesminsterium für Gesundheit, dieses vertr. durch das Robert-Koch-Institut Pharmazeutische Zusammensetzung, und ihr Verwendung zur prophylaktische und therapeutische Behandlung von retroviralen Krankenheiten

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4406885A (en) * 1978-12-28 1983-09-27 Research Corporation Preparation of native oncornavirus envelope subunits and vaccines therefrom
US4264587A (en) * 1979-08-01 1981-04-28 Pedersen Niels C Vaccine for preventing persistent feline leukemia viremia in cats
US4434158A (en) * 1981-02-11 1984-02-28 Cornell Research Foundation Cysteine delivery system
US4701416A (en) * 1983-12-09 1987-10-20 Cetus Corporation Feline leukemia virus vaccine plasmids for fusion protein of the gp70 envelope protein of FELV
EP0156299A3 (de) * 1984-03-26 1987-04-01 Chiron Corporation LTR-modifizierte virale Vakzine
EP0173997A1 (de) * 1984-09-06 1986-03-12 Chiron Corporation Katzenleukämievirusproteinimpfstoffe und ihre Herstellung
EP0203177A4 (de) * 1984-11-29 1987-04-28 Scripps Clinic Res Polypeptide und antikörper gegen entglykosilierte virale glykoproteine.
AU607399B2 (en) * 1985-09-09 1991-03-07 Cetus Corporation Infectious recombinant virus vaccine for feline leukemia

Also Published As

Publication number Publication date
ES2058113T3 (es) 1994-11-01
IL82720A0 (en) 1987-11-30
EP0247904B1 (de) 1993-08-25
ATE93394T1 (de) 1993-09-15
ZA873922B (en) 1988-02-24
JP2656521B2 (ja) 1997-09-24
PT84976A (pt) 1987-06-01
JPH01503273A (ja) 1989-11-09
DE3787121T2 (de) 1994-04-07
AU7547987A (en) 1987-12-22
AU607427B2 (en) 1991-03-07
EP0247904A1 (de) 1987-12-02
NZ220500A (en) 1991-05-28
PT84976B (pt) 1990-02-08
WO1987007301A1 (en) 1987-12-03
DK46988A (da) 1988-01-29
DE3787121D1 (de) 1993-09-30

Similar Documents

Publication Publication Date Title
MY103182A (en) Vaccines against acquired immune deficiency syndrome.
DK318481A (da) Syntetisk peptid specifik antigenisk determinant og fremgangsmaade til fremstilling af antigene meneraler deraf
ES537459A0 (es) Procedimiento para preparar anticuerpos anti-idiotipicos
EP0306524A4 (de) Von antikörpern, die unter verwendung eines eine beschränkte anzahl von antigenen präsentierenden pathogenen agens oder eines seiner derivate hergestellt worden sind, erkannte antigene determinanten.
DK388384D0 (da) Monoklone antistoffer med specifitet for membran-associerede antigene, deres fremstilling og anvendelse
NO165478C (no) Fremgangsmaate for fremstilling av antigeniske preparater.
DK163062C (da) Antigen, immunogen, proteinholdig vaccine imod coccidiose
DK120383A (da) Fremgangsmaade til fremstilling af konjugater af haptener og muramyl-peptider, der har immunogen virkning
DK304087D0 (da) Humant monoklonalt antistof mod lumfadenopati-associeret virus
NO870476D0 (no) Fremgangsmaate for fremstilling av kryss-beskyttende humane monoklonale antistoffpreparater.
DK46988D0 (da) Fremgangsmaade til fremstilling af katteleukaemivirusantigener og anvendelsen heraf
DE3879968D1 (de) Malaria-impfstoff aus copolymerem protein.
DK218886D0 (da) Tvaerreaktive og beskyttende epitoper af circumsporozoit-proteiner
DK282384D0 (da) Malariaassocieret antigen, fremgangsmaade til fremstilling deraf og vaccine indeholdende antigenet
KR890700683A (ko) 인체 면역 결핍 바이러스에 대한 항체 검색 방법
DE3751777D1 (de) Impfstoff, der zecken-antigene enthält
DK592284A (da) Toxoid, vaccinepraeparat indeholdende det og fremgangsmaade til fremstilling af det
DK313687D0 (da) Fremgangsmaade til fremstilling af et antigen og vaccine indeholdende dette antigen
DK0513565T3 (da) Monoklonale antistoffer mod plasmin-antiplasmin-komplekset, fremgangsmåde til deres fremstilling og deres anvendelse
WO1990015132A3 (en) Cloned treponema hyodysenteriae endoflagellar antigen
DK284389A (da) Precursorantigener
NO905619D0 (no) Identifikasjon av human-t-lymfocyt-epitoper i patogener for vaksine-utvikling.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment